Litcius/Paper detail

Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer

Ding Jianyi, Haili Gan, Bo Yin, Yang Meiqin, Huang Baoyou, Haoran Hu, Fang Li, Zheng Qingliang, Lingfei Han

2022Cancer Immunology Immunotherapy21 citationsDOIOpen Access PDF

Abstract

Immunosuppression induced by myeloid-derived suppressor cells (MDSCs) is one of the main obstacles to the efficacy of immunotherapy for cervical cancer. Recent studies on the immunosuppressive ability of MDSCs have primarily focused on T cells, but the effect of MDSCs on B cells function is still unclear. In a study of clinical specimens, we found that the accumulation of MDSCs in patients with cervical cancer was accompanied by high expression of B cell activating factor (BAFF) on the surface and high expression of interleukin (IL)-10-producing B cells (B10) in vivo. We found that the absence of BAFF could significantly inhibit tumor growth in a cervical cancer model using BAFF KO mice. Further studies showed that abundant MDSCs in cervical cancer induced B cells to differentiate into B10 cells by regulating BAFF which acted on the BAFF receptor (BAFF-R) of them. In this process, we found that a large amount of IL-10 secreted by B10 cells can activate STAT3 signaling pathway in MDSCs, and then form a positive feedback loop to promote the differentiation of B10 cells. Therefore, this study reveals a new mechanism of BAFF-mediated mutual immune regulation between MDSCs and B cells in the occurrence and development of cervical cancer.

Topics & Concepts

B-cell activating factorImmunosuppressionCancer researchMyeloid-derived Suppressor CellImmunologyCancer immunotherapyImmune systemImmunotherapyCancerMedicineSuppressorB cellAntibodyInternal medicineImmune cells in cancerReproductive System and PregnancyImmune Cell Function and Interaction
Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer | Litcius